Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.00
Bid: 21.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.524%)
Open: 21.50
High: 22.00
Low: 21.50
Prev. Close: 22.00
BKY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

25 Jan 2010 08:13

RNS Number : 0446G
Berkeley Resources Limited
25 January 2010
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, 

application for quotation of additional securities 

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

Berkeley Resources Limited

ABN

40 052 468 569

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1

+Class of +securities issued or to be issued

Ordinary Shares

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

10,600,000

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Fully paid ordinary shares

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

the date from which they do

the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

5

Issue price or consideration

$0.6762 each

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Exercise of Areva NC's Primary Options. Exercise price adjusted in accordance with Listing Rule 6.22 following completion of rights issue in June 2009.

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

25 January 2010

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

134,839,149

12,921,886

Ordinary shares

$0.75 Options

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

2,500,000

2,160,000

1,037,500

$1.00 Unlisted Options

$1.86 Incentive Options

$1.00 Incentive Options

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Not applicable

Part 2 ߛ Bonus issue or pro rata issue

11

Is security holder approval required?

Not applicable

12

Is the issue renounceable or non-renounceable?

Not applicable

13

Ratio in which the +securities will be offered

Not applicable

14

+Class of +securities to which the offer relates

Not applicable

15

+Record date to determine entitlements

Not applicable

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

Not applicable

17

Policy for deciding entitlements in relation to fractions

Not applicable

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

Not applicable

19

Closing date for receipt of acceptances or renunciations

Not applicable

20

Names of any underwriters

Not applicable

21

Amount of any underwriting fee or commission

Not applicable

22

Names of any brokers to the issue

Not applicable

23

Fee or commission payable to the broker to the issue

Not Applicable

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

Not applicable

25

If the issue is contingent on +security holders' approval, the date of the meeting

Not applicable

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

Not applicable

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

Not applicable

28

Date rights trading will begin (if applicable)

Not applicable

29

Date rights trading will end (if applicable)

Not applicable

30

How do +security holders sell their entitlements in full through a broker?

Not applicable

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

Not applicable

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

Not applicable

33

+Despatch date

Not applicable

  Part 3 ߛ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34

Type of securities 

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

37

A copy of any trust deed for the additional +securities

  

Entities that have ticked box 34(b)

38

Number of securities for which +quotation is sought

Not applicable

39

Class of +securities for which quotation is sought

Not applicable

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

the date from which they do

the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not applicable

41

Reason for request for quotation now 

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

Not applicable

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38) 

Not applicable

Quotation agreement

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

2 We warrant the following to ASX.

The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

There is no reason why those +securities should not be granted +quotation.

An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:  Date: 25 January 2010

(Director/Company secretary)

Print name:  Clint McGhie

== == == == ==

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEAPFSAFFEEEF
Date   Source Headline
12th Jul 20214:35 pmRNSPrice Monitoring Extension
12th Jul 20212:05 pmRNSSecond Price Monitoring Extn
12th Jul 20212:00 pmRNSPrice Monitoring Extension
12th Jul 20211:45 pmRNSPermitting Update
25th Jun 20218:29 amRNSAdmission of shares to trading
20th May 20212:05 pmRNSSecond Price Monitoring Extn
20th May 20212:00 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSUpdate on Spanish Regulatory Regime
29th Apr 20217:00 amRNSQuarterly Report March 2021
9th Apr 20217:00 amRNSUpdate on Spanish Regulatory Regime
26th Mar 20217:00 amRNSIssue of shares on exercise of unlisted options
10th Mar 20217:00 amRNSHalf-year Report
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20214:41 pmRNSSecond Price Monitoring Extn
24th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20212:06 pmRNSSecond Price Monitoring Extn
24th Feb 20212:01 pmRNSPrice Monitoring Extension
24th Feb 202111:06 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
24th Feb 20219:05 amRNSSecond Price Monitoring Extn
24th Feb 20219:00 amRNSPrice Monitoring Extension
24th Feb 20217:15 amRNSUpdate on Spanish Regulatory Regime
11th Feb 20214:35 pmRNSPrice Monitoring Extension
29th Jan 20217:00 amRNSQuarterly Report December 2020
4th Jan 20217:55 amRNSEU Home Member State
30th Dec 20207:55 amRNSReport on Payments to Govts
17th Dec 20207:00 amRNSOutstanding Contribution to Sustainable Mining
14th Dec 20207:00 amRNSMinistry Grants Renewal of Initial Authorisation
11th Dec 20204:41 pmRNSSecond Price Monitoring Extn
11th Dec 20204:35 pmRNSPrice Monitoring Extension
25th Nov 20207:55 amRNSResult of AGM
30th Oct 20207:55 amRNSQuarterly Report September 2020
19th Oct 20207:00 amRNSBerkeley included in IBEX Small Cap Index
16th Oct 20207:44 amRNSUpdate on Spanish Regulatory Regime
9th Oct 20207:55 amRNSNotice of AGM and Director Resignation
29th Sep 20207:55 amRNSAnnual Report to shareholders
16th Sep 20204:35 pmRNSPrice Monitoring Extension
8th Sep 20207:55 amRNSHolding(s) in Company
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
18th Aug 20204:40 pmRNSSecond Price Monitoring Extn
18th Aug 20204:36 pmRNSPrice Monitoring Extension
18th Aug 20202:05 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:35 pmRNSPrice Monitoring Extension
11th Aug 202011:38 amRNSUrbanism Licence Granted for Retortillo
30th Jul 20207:00 amRNSQuarterly Report June 2020
24th Jul 20207:00 amRNSNSC Recommends Extension of Initial Authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.